These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1934859)

  • 21. Is there a 'gold standard' for drug detection in pregnancy?
    Langkamp DL
    Am J Dis Child; 1992 Jan; 146(1):13-4. PubMed ID: 1736642
    [No Abstract]   [Full Text] [Related]  

  • 22. Drugs of abuse in maternal hair and paired neonatal meconium: an objective assessment of foetal exposure to gestational consumption.
    Joya X; Marchei E; Salat-Batlle J; García-Algar O; Calvaresi V; Pacifici R; Pichini S
    Drug Test Anal; 2016 Aug; 8(8):864-8. PubMed ID: 26627903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study.
    Ostrea EM; Brady M; Gause S; Raymundo AL; Stevens M
    Pediatrics; 1992 Jan; 89(1):107-13. PubMed ID: 1727992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meconium for drug testing.
    Maynard EC; Amoruso LP; Oh W
    Am J Dis Child; 1991 Jun; 145(6):650-2. PubMed ID: 1817465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of substance abuse monitoring in a social services context: a primer for child protection workers.
    Moller M; Gareri J; Koren G
    Can J Clin Pharmacol; 2010; 17(1):e177-93. PubMed ID: 20436210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substance use in rural Midwestern pregnant women.
    Yawn BP; Yawn RA; Uden DL
    Arch Fam Med; 1992 Sep; 1(1):83-8. PubMed ID: 1341592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meconium testing for cocaine metabolite: prevalence, perceptions, and pitfalls.
    Rosengren SS; Longobucco DB; Bernstein BA; Fishman S; Cooke E; Boctor F; Lewis SC
    Am J Obstet Gynecol; 1993 May; 168(5):1449-56. PubMed ID: 8498426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal hair analysis for the detection of illicit drugs, medicines, and alcohol exposure during pregnancy.
    Lendoiro E; González-Colmenero E; Concheiro-Guisán A; de Castro A; Cruz A; López-Rivadulla M; Concheiro M
    Ther Drug Monit; 2013 Jun; 35(3):296-304. PubMed ID: 23666580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of cocaine exposure in the neonate. Analyses of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine.
    Casanova OQ; Lombardero N; Behnke M; Eyler FD; Conlon M; Bertholf RL
    Arch Pathol Lab Med; 1994 Oct; 118(10):988-93. PubMed ID: 7944901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric fluid analysis for determining gestational cocaine exposure.
    Garcia DC; Romero A; Garcia GC; Ostrea EM
    Pediatrics; 1996 Aug; 98(2 Pt 1):291-3. PubMed ID: 8692634
    [No Abstract]   [Full Text] [Related]  

  • 31. The Association Between Antenatal Maternal Self-reported Substance Use, Maternal Characteristics, and Obstetrical Variables.
    Berra A; Kamo S; Mohnot S; Rosselot J; Suire A; Stafford J; Hagan J; Stafford I
    J Addict Med; 2019; 13(6):464-469. PubMed ID: 31033670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of exposure to drugs of abuse during pregnancy by hair analysis in a Mediterranean island.
    Friguls B; Joya X; Garcia-Serra J; Gómez-Culebras M; Pichini S; Martinez S; Vall O; Garcia-Algar O
    Addiction; 2012 Aug; 107(8):1471-9. PubMed ID: 22296208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison and validation of screening tools for substance use in pregnancy: a cross-sectional study conducted in Maryland prenatal clinics.
    Coleman-Cowger VH; Oga EA; Peters EN; Trocin K; Koszowski B; Mark K
    BMJ Open; 2018 Feb; 8(2):e020248. PubMed ID: 29455170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The substance abuse subtle screening inventory minimizes the need for toxicology screening of prenatal patients.
    Horrigan TJ; Piazza N
    J Subst Abuse Treat; 1999 Oct; 17(3):243-7. PubMed ID: 10531631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drugs of abuse testing.
    Coffman NB; Fernandes J
    J Am Osteopath Assoc; 1991 Apr; 91(4):385-8, 395-6. PubMed ID: 1874647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implicit Bias in Prenatal Drug Testing.
    Odeyomi F
    Tex Med; 2020 Jun; 116(6):6. PubMed ID: 32872704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for substance abuse in pregnancy.
    Jimerson SD; Musick S
    J Okla State Med Assoc; 2013 Apr; 106(4):133-4. PubMed ID: 23795524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug use and pregnancy - challenges for public health.
    Gyarmathy VA; Giraudon I; Hedrich D; Montanari L; Guarita B; Wiessing L
    Euro Surveill; 2009 Mar; 14(9):33-6. PubMed ID: 19317968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of prenatal drug exposure in the pregnant woman and her newborn infant.
    Ostrea EM
    NIDA Res Monogr; 1992; 117():61-79. PubMed ID: 1620211
    [No Abstract]   [Full Text] [Related]  

  • 40. Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids.
    Carlier J; La Maida N; Di Trana A; Huestis MA; Pichini S; Busardò FP
    Ther Drug Monit; 2020 Apr; 42(2):205-221. PubMed ID: 31809406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.